Get the Stockscreener App
33.62
5.42%
1.73
Omnicell Inc stock is traded at $33.62, with a volume of 863.92K.
It is up +5.42% in the last 24 hours and up +18.97% over the past month.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
See More
Previous Close:
$31.89
Open:
$32.16
24h Volume:
863.92K
Relative Volume:
1.62
Market Cap:
$1.54B
Revenue:
$1.15B
Net Income/Loss:
$23.09M
P/E Ratio:
67.24
EPS:
0.5
Net Cash Flow:
$89.18M
1W Performance:
+6.09%
1M Performance:
+18.97%
6M Performance:
-15.36%
1Y Performance:
-20.93%
1-Day Range:
$32.10
$33.71
1-Week Range:
$31.34
$33.71
52-Week Range:
$22.66
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Name
Omnicell Inc
Sector
Industry
Phone
(877) 415-9990
Address
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
33.62 | 1.45B | 1.15B | 23.09M | 89.18M | 0.50 |
|
VEEV
Veeva Systems Inc
|
290.86 | 46.10B | 2.86B | 780.66M | 1.19B | 4.72 |
|
TEM
Tempus Ai Inc
|
80.52 | 13.63B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.74 | 12.35B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.82 | 7.74B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.24 | 6.32B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-02-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-03-24 | Initiated | Barclays | Underweight |
| Nov-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-03-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-03-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-11-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-26-23 | Reiterated | Wells Fargo | Underweight |
| Aug-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-23 | Downgrade | Wells Fargo | Overweight → Underweight |
| Feb-27-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-03-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-22 | Initiated | BofA Securities | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Mkt Perform |
| Dec-06-21 | Resumed | Wells Fargo | Overweight |
| Jun-09-21 | Initiated | JP Morgan | Neutral |
| May-24-21 | Initiated | BTIG Research | Buy |
| Feb-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Dec-03-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Feb-07-20 | Reiterated | Dougherty & Company | Buy |
| Nov-21-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-19 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-07-19 | Reiterated | Dougherty & Company | Buy |
| Jun-29-18 | Resumed | The Benchmark Company | Buy |
| Sep-05-17 | Reiterated | The Benchmark Company | Buy |
| Jul-28-17 | Reiterated | Dougherty & Company | Buy |
| Apr-21-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-19-17 | Initiated | Dougherty & Company | Buy |
| Dec-06-16 | Reiterated | The Benchmark Company | Buy |
| Jul-07-16 | Reiterated | FBR Capital | Outperform |
| Mar-21-16 | Reiterated | Topeka Capital Markets | Buy |
| Jan-07-16 | Initiated | The Benchmark Company | Buy |
| Nov-16-15 | Reiterated | Topeka Capital Markets | Buy |
| Oct-30-15 | Reiterated | FBR Capital | Outperform |
| Sep-28-15 | Upgrade | Sidoti | Neutral → Buy |
| Jul-31-15 | Reiterated | Topeka Capital Markets | Buy |
View All
Omnicell Inc Stock (OMCL) Latest News
How to integrate Omnicell Inc. into portfolio analysis tools2025 Top Gainers & Real-Time Market Trend Scan - Newser
How to use Fibonacci retracement on Omnicell Inc.2025 Year in Review & Weekly Top Gainers Alerts - Newser
Key metrics from Omnicell Inc.’s quarterly dataTrade Exit Summary & Technical Pattern Based Buy Signals - Newser
Is Omnicell Inc. a candidate for recovery playWeekly Profit Analysis & Consistent Return Investment Signals - Newser
Sector ETF performance correlation with Omnicell Inc.Weekly Loss Report & Verified Momentum Watchlists - Newser
KeyBanc reiterates Sector Weight rating on Omnicell stock - Investing.com
Real time pattern detection on Omnicell Inc. stockQuarterly Trade Summary & Intraday High Probability Alerts - Newser
Has Omnicell Inc. formed a bullish divergenceJuly 2025 Short Interest & Safe Capital Growth Trade Ideas - Newser
What moving averages say about Omnicell Inc.Stop Loss & Technical Pattern Based Signals - Newser
Technical signs of recovery in Omnicell Inc.July 2025 Breakouts & Free Verified High Yield Trade Plans - Newser
Sentiment analysis tools applied to Omnicell Inc.July 2025 Price Swings & AI Powered Market Trend Analysis - Newser
Is Omnicell Inc. showing signs of accumulationJuly 2025 Institutional & Intraday High Probability Alerts - Newser
Can trapped investors hope for a rebound in Omnicell Inc.Trade Exit Summary & Weekly High Potential Stock Alerts - Newser
Evaluating Omnicell Inc. with trendline analysisEarnings Risk Summary & Technical Buy Zone Confirmation - Newser
Visual analytics tools that track Omnicell Inc. performanceJuly 2025 Update & Safe Entry Zone Identification - Newser
Is This the Dip to Buy in Omnicell Inc.Market Movement Recap & Low Risk Entry Point Tips - classian.co.kr
What earnings revisions data tells us about Omnicell Inc.Insider Selling & Verified Swing Trading Watchlist - Newser
Is it too late to sell Omnicell Inc.July 2025 Snapshot & Free Low Drawdown Momentum Trade Ideas - Newser
Using R and stats models for Omnicell Inc. forecasting2025 Support & Resistance & Intraday High Probability Setup Alerts - Newser
What makes Omnicell Inc. stock price move sharply2025 Support & Resistance & Consistent Profit Alerts - Newser
Inside Omnicell’s Austin Lab: Building the Pharmacy of the Future with AI and Robotics - KEYE
Omnicell Inc. Bounces Off Moving Average SupportEarnings Performance Report & Smart Allocation Stock Tips - beatles.ru
Omnicell Inc. recovery potential after sell offQuarterly Growth Report & Community Driven Trade Alerts - Newser
Pharmacy Automation Company Evaluation Report 2025 | BD, Omnicell, and Capsa Healthcare Lead in Medical Technology, Pharmacy Automation, and Medication Management Solutions - Yahoo Finance
How to escape a deep drawdown in Omnicell Inc.Quarterly Portfolio Report & Weekly Setup with ROI Potential - Newser
Is Omnicell Inc. stock bottoming outEarnings Growth Summary & Stock Portfolio Risk Control - Newser
Omnicell outlines $40M tariff impact and anticipates $1.105B-$1.155B revenue for 2025 - MSN
Trapped Investors in Omnicell Inc. Await Breakout SignalBull Run & Safe Entry Momentum Stock Tips - beatles.ru
OMCL Q2 Deep Dive: Product Innovation and Recurring Revenue Drive Upbeat Guidance - Yahoo Finance
5 Must-Read Analyst Questions From Omnicell’s Q2 Earnings Call - Yahoo Finance
Did Strong Q2 Results and Improved Profitability Just Shift Omnicell’s (OMCL) Investment Narrative? - simplywall.st
Omnicell (NASDAQ:OMCL) Given a $55.00 Price Target by Piper Sandler Analysts - Defense World
Omnicell (NASDAQ:OMCL) PT Set at $55.00 by Piper Sandler - Defense World
Bruker, Viatris, Sotera Health Company, Align Technology, and Omnicell Stocks Trade Up, What You Need To Know - Yahoo Finance
Piper Sandler Maintains Omnicell(OMCL.US) With Buy Rating, Cuts Target Price to $55 - 富途牛牛
Omnicell price target lowered to $55 from $57 at Piper Sandler - TipRanks
Piper Sandler lowers Omnicell stock price target to $55 on tariff concerns - Investing.com Nigeria
Omnicell, Inc. (NASDAQ:OMCL) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Omnicell (NASDAQ:OMCL) Downgraded to “Buy” Rating by Wall Street Zen - Defense World
Best data tools to analyze Omnicell Inc. stockFree Trade Ready Stock Watch for Short Term - Newser
Does Omnicell Inc. show high probability of reboundPredictive System for Long-Term Stock Forecast - Newser
Intraday pattern recognizer results for Omnicell Inc.Portfolio Booster Strategy with Trend Confidence - Newser
Why Omnicell Inc. stock attracts strong analyst attentionEntry and Exit Strategy for Swing Traders - Newser
Can Omnicell Inc. rally from current levelsTriple Digit Gain Opportunity Watchlist - Newser
Central Fill Pharmacy Automation Market is evolving rapidly ThroNORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA
Price action breakdown for Omnicell Inc.AI Triggered Buy Zone Forecast System - Newser
How Investors Are Reacting To Omnicell (OMCL) Q2 Revenue Growth and Raised Full-Year Guidance - simplywall.st
Omnicell 2025 Q2 Earnings Strong Performance as Net Income Surges 51% - AInvest
Omnicell’s Earnings Call Highlights Strong Growth and Strategic Wins - The Globe and Mail
Omnicell Inc Stock (OMCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Omnicell Inc Stock (OMCL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| PARRISH MARK W | Director |
Dec 10 '24 |
Sale |
47.30 |
12,000 |
567,638 |
58,427 |
1.72%
0.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):